Dermatology Drugs Market Report

China Dermatology Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 16, 2023
  • PAGES：146
  • REPORT CODE：GMM1801288
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

    This report elaborates on the current development of the Dermatology Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • LEO Pharma

    • Bayer

    • Merz Pharma

    • Valeant

    • Novartis

    • GlaxoSmithKline

    • Pfizer

    • Johnson & Johnson

    • Galderma

    By Type:

    • Injection

    • Oral

    • External Use

    By Application:

    • Dermatitis

    • Skin Infections

    • Other

    • Acne

    • Psoriasis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Dermatology Drugs Market Overview 2018-2029

    • 1.1 China Dermatology Drugs Industry Development Overview

    • 1.2 China Dermatology Drugs Industry Development History

    • 1.3 China Dermatology Drugs Industry Market Size (2018-2029)

    • 1.4 China Dermatology Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Dermatology Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

      • 1.4.2 China Dermatology Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

      • 1.4.3 China Dermatology Drugs Production Volume, Production Value and Growth Rate of External Use (2018-2029)

    • 1.5 China Dermatology Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Dermatitis (2018-2029)

      • 1.5.2 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Skin Infections (2018-2029)

      • 1.5.3 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.4 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Acne (2018-2029)

      • 1.5.5 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Psoriasis (2018-2029)

    • 1.6 China Dermatology Drugs Market Analysis by Region

      • 1.6.1 North China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Dermatology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Dermatology Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Dermatology Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Dermatology Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Dermatology Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Dermatology Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Dermatology Drugs Industry Development

    Chapter 3 Dermatology DrugsIndustry Chain Analysis

    • 3.1 Dermatology Drugs Industry Chain

    • 3.2 Dermatology Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Dermatology Drugs Market

    • 3.3 Dermatology Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Dermatology Drugs Market

    Chapter 4 China Dermatology Drugs Market, by Type

    • 4.1 China Dermatology Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Dermatology Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Dermatology Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Dermatology Drugs Production Volume and Growth Rate of Injection

      • 4.5.2 China Dermatology Drugs Production Volume and Growth Rate of Oral

      • 4.5.3 China Dermatology Drugs Production Volume and Growth Rate of External Use

    Chapter 5 China Dermatology Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Dermatology Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Dermatology Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Dermatology Drugs Market Size and Growth Rate of Dermatitis

      • 5.5.2 China Dermatology Drugs Market Size and Growth Rate of Skin Infections

      • 5.5.3 China Dermatology Drugs Market Size and Growth Rate of Other

      • 5.5.4 China Dermatology Drugs Market Size and Growth Rate of Acne

      • 5.5.5 China Dermatology Drugs Market Size and Growth Rate of Psoriasis

    Chapter 6 China Dermatology Drugs Market, by Region

    • 6.1 China Dermatology Drugs Production Volume and Production Value, by Region

    • 6.2 China Dermatology Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Dermatology Drugs Market Analysis

    • 7.1 North China Dermatology Drugs Market, by Type

    • 7.2 North China Dermatology Drugs Market, by Application

    Chapter 8 Central China Dermatology Drugs Market Analysis

    • 8.1 Central China Dermatology Drugs Market, by Type

    • 8.2 Central China Dermatology Drugs Market, by Application

    Chapter 9 South China Dermatology Drugs Market Analysis

    • 9.1 South China Dermatology Drugs Market, by Type

    • 9.2 South China Dermatology Drugs Market, by Application

    Chapter 10 East China Dermatology Drugs Market Analysis

    • 10.1 East China Dermatology Drugs Market, by Type

    • 10.2 East China Dermatology Drugs Market, by Application

    Chapter 11 Northeast China Dermatology Drugs Market Analysis

    • 11.1 Northeast China Dermatology Drugs Market, by Type

    • 11.2 Northeast China Dermatology Drugs Market, by Application

    Chapter 12 Southwest China Dermatology Drugs Market Analysis

    • 12.1 Southwest China Dermatology Drugs Market, by Type

    • 12.2 Southwest China Dermatology Drugs Market, by Application

    Chapter 13 Northwest China Dermatology Drugs Market Analysis

    • 13.1 Northwest China Dermatology Drugs Market, by Type

    • 13.2 Northwest China Dermatology Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 LEO Pharma

        • 14.1.1 LEO Pharma Company Profile

        • 14.1.2 LEO Pharma Dermatology Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bayer

        • 14.2.1 Bayer Company Profile

        • 14.2.2 Bayer Dermatology Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merz Pharma

        • 14.3.1 Merz Pharma Company Profile

        • 14.3.2 Merz Pharma Dermatology Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Valeant

        • 14.4.1 Valeant Company Profile

        • 14.4.2 Valeant Dermatology Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis

        • 14.5.1 Novartis Company Profile

        • 14.5.2 Novartis Dermatology Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline

        • 14.6.1 GlaxoSmithKline Company Profile

        • 14.6.2 GlaxoSmithKline Dermatology Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Dermatology Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson & Johnson

        • 14.8.1 Johnson & Johnson Company Profile

        • 14.8.2 Johnson & Johnson Dermatology Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Galderma

        • 14.9.1 Galderma Company Profile

        • 14.9.2 Galderma Dermatology Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Dermatology Drugs Industry Research Conclusions

    • 15.2 Dermatology Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Dermatology Drugs Industry Market Size (2018-2029)

    • Figure China Dermatology Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Dermatology Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Dermatology Drugs Production Volume, Production Value and Growth Rate of External Use (2018-2029)

    • Figure China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Dermatitis (2018-2029)

    • Figure China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Skin Infections (2018-2029)

    • Figure China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Acne (2018-2029)

    • Figure China Dermatology Drugs Sales Volume, Sales Value and Growth Rate of Psoriasis (2018-2029)

    • Figure North China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Dermatology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Dermatology Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Dermatology Drugs Market Share by Type in 2018

    • Figure China Dermatology Drugs Market Share by Type in 2023

    • Figure China Dermatology Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Dermatology Drugs Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Dermatology Drugs Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Dermatology Drugs Production Volume and Growth Rate of External Use (2018-2023)

    • Figure China Dermatology Drugs Market Share by Application in 2018

    • Figure China Dermatology Drugs Market Share by Application in 2023

    • Figure China Dermatology Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Dermatology Drugs Market Size and Growth Rate of Dermatitis (2018-2023)

    • Figure China Dermatology Drugs Market Size and Growth Rate of Skin Infections (2018-2023)

    • Figure China Dermatology Drugs Market Size and Growth Rate of Other (2018-2023)

    • Figure China Dermatology Drugs Market Size and Growth Rate of Acne (2018-2023)

    • Figure China Dermatology Drugs Market Size and Growth Rate of Psoriasis (2018-2023)

    • Table China Dermatology Drugs Production Volume by Region (2018-2023)

    • Table China Dermatology Drugs Production Volume Share by Region (2018-2023)

    • Figure China Dermatology Drugs Production Volume Share by Region (2018-2023)

    • Table China Dermatology Drugs Production Value by Region (2018-2023)

    • Table China Dermatology Drugs Production Value Share by Region (2018-2023)

    • Figure China Dermatology Drugs Production Value Share by Region (2018-2023)

    • Table China Dermatology Drugs Sales Volume by Region (2018-2023)

    • Table China Dermatology Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Dermatology Drugs Sales Volume Share by Region (2018-2023)

    • Table China Dermatology Drugs Sales Value by Region (2018-2023)

    • Table China Dermatology Drugs Sales Value Share by Region (2018-2023)

    • Figure China Dermatology Drugs Sales Value Share by Region (2018-2023)

    • Table North China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table North China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table North China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table North China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table Central China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table Central China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table South China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table South China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table South China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table East China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table East China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table East China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Dermatology Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Dermatology Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Dermatology Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Dermatology Drugs Sales Volume Share by Application (2018-2023)

    • Table LEO Pharma Company Profile

    • Table LEO Pharma Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Merz Pharma Company Profile

    • Table Merz Pharma Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Valeant Company Profile

    • Table Valeant Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Dermatology Drugs Revenue, Price and Gross (2018-2023)

    • Table Galderma Company Profile

    • Table Galderma Dermatology Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US